BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rashid AB, Grossniklaus HE. Clinical, pathologic, and imaging features and biological markers of uveal melanoma. Methods Mol Biol 2014;1102:397-425. [PMID: 24258990 DOI: 10.1007/978-1-62703-727-3_21] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Yanoff M, Sassani JW. Ocular Melanocytic Tumors. Ocular Pathology. Elsevier; 2020. pp. 658-725.e3. [DOI: 10.1016/b978-0-323-54755-0.00017-6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Zhou J, Jiang J, Wang S, Xia X. Oncogenic role of microRNA‑20a in human uveal melanoma. Mol Med Rep 2016;14:1560-6. [PMID: 27356499 DOI: 10.3892/mmr.2016.5433] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
3 Russo A, Caltabiano R, Longo A, Avitabile T, Franco LM, Bonfiglio V, Puzzo L, Reibaldi M. Increased Levels of miRNA-146a in Serum and Histologic Samples of Patients with Uveal Melanoma. Front Pharmacol 2016;7:424. [PMID: 27895580 DOI: 10.3389/fphar.2016.00424] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
4 Li Z, Yu X, Shen J, Jiang Y. MicroRNA dysregulation in uveal melanoma: a new player enters the game. Oncotarget 2015;6:4562-8. [PMID: 25682876 DOI: 10.18632/oncotarget.2923] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 10.0] [Reference Citation Analysis]
5 Bustamante P, Piquet L, Landreville S, Burnier JV. Uveal melanoma pathobiology: Metastasis to the liver. Semin Cancer Biol 2021;71:65-85. [PMID: 32450140 DOI: 10.1016/j.semcancer.2020.05.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Sun L, Bian G, Meng Z, Dang G, Shi D, Mi S. MiR-144 Inhibits Uveal Melanoma Cell Proliferation and Invasion by Regulating c-Met Expression. PLoS One 2015;10:e0124428. [PMID: 25961751 DOI: 10.1371/journal.pone.0124428] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
7 Ragusa M, Barbagallo C, Statello L, Caltabiano R, Russo A, Puzzo L, Avitabile T, Longo A, Toro MD, Barbagallo D, Valadi H, Di Pietro C, Purrello M, Reibaldi M. miRNA profiling in vitreous humor, vitreal exosomes and serum from uveal melanoma patients: Pathological and diagnostic implications. Cancer Biol Ther 2015;16:1387-96. [PMID: 25951497 DOI: 10.1080/15384047.2015.1046021] [Cited by in Crossref: 69] [Cited by in F6Publishing: 71] [Article Influence: 9.9] [Reference Citation Analysis]
8 Hu K, Babapoor-Farrokhran S, Rodrigues M, Deshpande M, Puchner B, Kashiwabuchi F, Hassan SJ, Asnaghi L, Handa JT, Merbs S, Eberhart CG, Semenza GL, Montaner S, Sodhi A. Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma. Oncotarget 2016;7:7816-28. [PMID: 26761211 DOI: 10.18632/oncotarget.6868] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 10.0] [Reference Citation Analysis]